FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

TRACKING RETINAL THINNING IN MS PATIENTS




























Image Source: PINSTAKE

New study emphasises optical coherence tomography as a key tool for predicting multiple sclerosis worsening

OCT testing of retinal thickness by an optometrist should be part of the yearly optical monitoring of multiple sclerosis (MS) patients, new research suggests.

The thinning of the peripapillary retinal nerve fibre layer (pRNFL) can predict the progression of the degenerative disease, a new Lancet Neurology paper concludes.

The cohort study was conducted in Canada, the Czech Republic, France, Germany, Italy, the Netherlands, Spain and the US. A total of 879 patients, who had several types of MS but not optic neuritis, were recruited then tracked for an average of two years.

The symptoms of 252 patients had worsened during the study, and patients with thinner pRNFL were more likely to see their disease progress, research co-author, Dr Pablo Villoslada, told OT.

The study also tracked macular volume, but found no associations between this and disease development.

The 43-person research team concluded that monitoring pRNFL thickness using OCT was a useful predictor that a patient’s disease would worsen.

Dr Villoslada, of the Spanish August Pi i Sunyer Biomedical Research Institute, said that neurologists tracking MS patients should request yearly OCT tests from an optometrist.

His hospital’s neurology department has its own optometrist to conduct such monitoring, he explained. “They work in the neurology outpatient clinic. An ophthalmologist reviews the OCT test from the first visit for incidental findings. This works easily and everybody is happy with the solution,” he noted.

Previous research has shown thinning retinas are associated with multiple sclerosis and other neurological degenerative conditions, such as Alzheimer’s and Parkinson’s diseases.

Dr Villoslada’s team is currently assessing whether OCT monitoring of pRNFL could predict the progression of such conditions as well as MS.

Story Source: The above story is based on materials provided by OPTOMETRYTODAY
Note: Materials may be edited for content and length


Labels:



Go to Newer News Go to Older News